000285675 001__ 285675
000285675 005__ 20240328112643.0
000285675 0247_ $$2doi$$a10.3389/fimmu.2023.1272018
000285675 0247_ $$2altmetric$$aaltmetric:156278593
000285675 037__ $$aDKFZ-2023-02497
000285675 082__ $$a610
000285675 1001_ $$0P:(DE-HGF)0$$aMariz, Filipe Colaco$$b0$$eFirst author
000285675 245__ $$aAdvances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2
000285675 260__ $$aLausanne$$bFrontiers Media$$c2023
000285675 3367_ $$2DRIVER$$aarticle
000285675 3367_ $$2DataCite$$aOutput Types/Journal article
000285675 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1711621580_3151
000285675 3367_ $$2BibTeX$$aARTICLE
000285675 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000285675 3367_ $$00$$2EndNote$$aJournal Article
000285675 500__ $$a#EA:F035#LA:F035# / EMBL-DKFZ Chemical Biology Core Facility
000285675 536__ $$0G:(DE-HGF)POF4-316$$a316 - Infektionen, Entzündung und Krebs (POF4-316)$$cPOF4-316$$fPOF IV$$x0
000285675 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000285675 7001_ $$0P:(DE-He78)04eb74f47fce0fa7e60ef3880ee01ada$$aPutzker, Kerstin$$b1$$udkfz
000285675 7001_ $$0P:(DE-He78)219d54a7bf634121fbf16bea82d434e1$$aSehr, Peter$$b2$$udkfz
000285675 7001_ $$0P:(DE-He78)47d2c5b8ee00ab8a0c16e14137427579$$aMüller, Martin$$b3$$eLast author$$udkfz
000285675 773__ $$0PERI:(DE-600)2606827-8$$a10.3389/fimmu.2023.1272018$$gVol. 14, p. 1272018$$p1272018$$tFrontiers in immunology$$v14$$x1664-3224$$y2023
000285675 909CO $$ooai:inrepo02.dkfz.de:285675$$pVDB
000285675 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000285675 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)04eb74f47fce0fa7e60ef3880ee01ada$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000285675 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)219d54a7bf634121fbf16bea82d434e1$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000285675 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)47d2c5b8ee00ab8a0c16e14137427579$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000285675 9131_ $$0G:(DE-HGF)POF4-316$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfektionen, Entzündung und Krebs$$x0
000285675 9141_ $$y2023
000285675 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT IMMUNOL : 2022$$d2023-10-26
000285675 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-26
000285675 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-26
000285675 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-26
000285675 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-11T10:28:02Z
000285675 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-11T10:28:02Z
000285675 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2021-05-11T10:28:02Z
000285675 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-05-11T10:28:02Z
000285675 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-26
000285675 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-26
000285675 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-26
000285675 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-26
000285675 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bFRONT IMMUNOL : 2022$$d2023-10-26
000285675 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-26
000285675 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-26
000285675 9202_ $$0I:(DE-He78)F035-20160331$$kF035$$lTumorvirus-spez. Vakzinierungsstrategie$$x0
000285675 9201_ $$0I:(DE-He78)F035-20160331$$kF035$$lTumorvirus-spez. Vakzinierungsstrategie$$x0
000285675 9201_ $$0I:(DE-He78)W040-20160331$$kW040$$lGruppe Sehr EMBL$$x1
000285675 9200_ $$0I:(DE-He78)F035-20160331$$kF035$$lTumorvirus-spez. Vakzinierungsstrategie$$x0
000285675 980__ $$ajournal
000285675 980__ $$aVDB
000285675 980__ $$aI:(DE-He78)F035-20160331
000285675 980__ $$aI:(DE-He78)W040-20160331
000285675 980__ $$aUNRESTRICTED